Low-Risk, Early Stage Breast Cancer
1 clinical trials · Condition
◉ Watch Low-Risk, Early Stage Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial) (NCT07629206) | IceCure Medical Ltd. | 2026-07-17 |
Track Low-Risk, Early Stage Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.